Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Board changes and trading update

30 Jan 2015 07:00

RNS Number : 5581D
Plant Health Care PLC
30 January 2015
 



30 Jan 2015

 

PLANT HEALTH CARE plc

 

("Plant Health Care" or the "Company")

 

Board changes and trading update

Plant Health Care announces organisation changes and a pre-close trading statement in respect of the year ended 31 December 2014.

Plant Health Care (AIM: PHC), a leading provider of novel patent-protected biological products to the global agriculture markets, is pleased to announce that Dr. Richard Webb, formerly a Non-Executive Director, has become an Executive Director of Plant Health Care plc. Richard will be responsible for supporting the Chief Scientific Officer, Dr. Zhongmin Wei, as the company continues to expand its research and development programme.

Richard will step down from the Audit Committee and be replaced by James Ede-Golightly. In due course, the company intends to appoint an additional independent non-executive director with extensive commercial experience in the sector.

During 2014, the Company continued to make substantial progress in our core research objectives, as evidenced by the launch of the Innatus 3G™ technology platform. Major industry players have responded positively to Innatus 3G and we are in active discussions with them as we pursue potential partnerships. Our intellectual property portfolio continues to strengthen our leading position in protein-based bio-stimulants. Regarding our existing products, we have added material new distribution agreements over recent months, which we anticipate will lead to further sales growth as registrations are obtained outside current markets. We are actively exploring options to extend and accelerate sales further.

Revenue for the year ended 31 December 2014 amounted to $6.9 million, of which $0.15 million was one-off milestone payments. The company's sales of proprietary products (excluding one-off payments) grew 40% over 2013 with combined sales of Harpin and Myconate reaching $3.5 million.

Cash and investments at the year-end were $16.7 million.

More details will be provided in the announcement of the Company's 2014 results, scheduled for 30 March 2015.

- ENDS -

For further information, please contact:

Plant Health Care plc

Paul Schmidt, Chief Executive Officer Tel: +1 (919) 926 1600

 

Liberum Capital - Nomad and Broker

Clayton Bush Tel: +44 (0) 20 3100 2000

 

LHA

Ed McGregor / Jody Burfening Tel: +1 (212) 838 3777

 

Company website: www.planthealthcare.com

 

About Plant Health Care: Plant Health Care is a leading provider of novel patent-protected biological products to the global agriculture markets. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. The Company's ordinary shares have been quoted on the AIM market of the London Stock Exchange since July 2004 (ticker symbol: PHC).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEADFNAEESEAF
Date   Source Headline
3rd Aug 20177:00 amRNSHolding(s) in Company
12th Jul 20174:09 pmRNSGrant of options
30th Jun 20173:30 pmRNSHolding(s) in Company
15th Jun 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20174:35 pmRNSPrice Monitoring Extension
6th Jun 20177:00 amRNSNew Technology Update
31st May 20177:00 amRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSDirector/PDMR Shareholding
22nd May 20177:00 amRNSGrant of options
11th May 201712:50 pmRNSResult of AGM
27th Apr 20177:00 amRNSPublication of Annual Report and Notice of AGM
10th Apr 20177:00 amRNSResults for the Year Ended 31 December 2016
5th Apr 20174:49 pmRNSChange of Registered Office
5th Apr 20177:00 amRNSHolding(s) in Company
5th Apr 20177:00 amRNSHolding(s) in Company
20th Feb 20177:01 amRNSDirector/PDMR Shareholding
20th Feb 20177:00 amRNSBlock listing Interim Review
8th Feb 20177:00 amRNSHolding(s) in Company
18th Jan 20177:02 amRNSResearch Update
18th Jan 20177:00 amRNSTrading Statement
19th Dec 20164:40 pmRNSSecond Price Monitoring Extn
19th Dec 20164:35 pmRNSPrice Monitoring Extension
14th Dec 20164:40 pmRNSSecond Price Monitoring Extn
14th Dec 20164:35 pmRNSPrice Monitoring Extension
14th Dec 20167:00 amRNSNew Commercial Distribution Agreements
30th Nov 20167:00 amRNSDirectorate Change
17th Oct 20167:00 amRNSDirectorate Change
14th Sep 20167:00 amRNSHalf-year Report
31st Aug 20164:30 pmRNSTotal Voting Rights
23rd Aug 20162:54 pmRNSHolding(s) in Company
23rd Aug 20167:00 amRNSBlock listing Interim Review
23rd Aug 20167:00 amRNSDirector/PDMR Shareholding
22nd Aug 20163:44 pmRNSHolding(s) in Company
22nd Aug 20163:38 pmRNSHolding(s) in Company
16th Aug 201611:41 amRNSResult of General Meeting, Placing & Open Offer
29th Jul 20167:00 amRNSProposed Placing, Subscription and Open Offer
7th Jun 20167:00 amRNSProgress on New Technology Builds Momentum
23rd May 20163:09 pmRNSResult of AGM
17th May 20163:45 pmRNSChange of Registered Office Address
25th Apr 20167:00 amRNSAnnual Financial Report
8th Apr 20167:00 amRNSAnnual Financial Report
22nd Feb 20167:00 amRNSBlocklisting Interim Review
2nd Feb 20167:00 amRNSReduced Disclosure Framework
29th Jan 20167:00 amRNSTrading Statement
2nd Dec 20157:00 amRNSPHC Expands Distribution Agreement with Sym-Agro
1st Dec 20157:00 amRNSPHC notification of major interest in shares
30th Nov 20157:00 amRNSPHC and Arysta LifeScience Terminate Agreement
30th Oct 20151:21 pmRNSTotal Voting Rights
30th Sep 20153:47 pmRNSTotal Voting Rights
25th Sep 20157:00 amRNSRe Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.